Contact
      Please use this form to send email to PR contact of this press release:
      
      Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter
    
      TO: